PPAR-γ agonist monascin significantly lowed the water content of brain tissue around hematoma while PPAR-γ antagonist Glivec acted the opposite way, in comparison with the vehicle group (#p < 0.05; Figure 1). This evidence concerns the gene PPARG and hematoma.